Clinical trial
Novel Salivary Rapid Testing of SARS_CoV_2
NCT04877002 is registered in ClinicalTrials.gov with Sona Nanotech Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Salivary Rapid Testing of SARS_CoV_2
- Lead sponsor
- Sona Nanotech Inc
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 29, 2021
- Completion date
- January 5, 2022
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
corona virus infection, covid19, sars-cov-2 infection